Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 9 recruiting now early-phase tilt small index

Acute Pancreatitis: early-phase trial registry

9 of 11 indexed Acute Pancreatitis trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,577 of 28,707 conditions by registered trial count.

11 US clinical trials · 9 currently recruiting · #1,577 of 28,707 conditions by registered trial count

Acute Pancreatitis: 11 US clinical trials tracked, 9 recruiting.

Acute Pancreatitis is the subject of 11 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Milton S. Hershey Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition acute-pancreatitis

OPEN 9 | RECR 82% | LATE 0 | EARLY 4 | RANK #1577 | SPON 2

Nearest open-share peer: Gynecologic Cancers (82% recruiting · 11 trials)

Acute Pancreatitis (this)82%Acute Stroke45.5%Acquired Brain Injury36.4%Adenocarcinoma of the Pancre18.2%Acute Lung Injury9.1%
Open-enrollment share among volume-matched conditions near Acute Pancreatitis

Acute Pancreatitis lists 9 open slots (82% of 11 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Acute Pancreatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Acute Pancreatitis is recruiting above its size-band peers.

    9 of 11 indexed trials (81.8%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Acute Pancreatitis research.

    Milton S. Hershey Medical Center accounts for 2 of 11 trials (18.2%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Acute Pancreatitis enrolment sits around 198 participants.

    Median target enrolment is 198 among the 11 trials that report a genuine target (sentinel values excluded). 5 of those (45.5%) plan for fewer than 100 participants.

  4. Acute Pancreatitis splits between interventional and observational designs.

    5 interventional and 6 observational studies make up this index (45.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 22

Open and recent trials

11 total, page 1 of 1

RECRUITING 20,000 participants

Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

Mayo Clinic

NCT00830557

RECRUITING 1,000 participants

Registry of Patients Undergoing Endoscopic Management of Pancreatic Fluid Collections

Orlando Health

NCT06179459

RECRUITING 800 participants

Diabetes RElated to Acute Pancreatitis and Its Mechanisms

Milton S. Hershey Medical Center

NCT05197920

RECRUITING 800 participants

Diabetes RElated to Acute Pancreatitis and Its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics

Milton S. Hershey Medical Center

NCT06401577

RECRUITING 198 participants

iMmune SignAtures and Clinical outComes in AP

Ohio State University

NCT05878236

RECRUITING 45 participants

DEciphering CIrculating SIgnatures Of Infected Pancreatic Necrosis

University of Minnesota

NCT06899087

RECRUITING Phase 1 42 participants

Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase

St. Jude Children's Research Hospital

NCT04195347

RECRUITING Phase 2 36 participants

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Panafina

NCT06080789

RECRUITING NA 20 participants

Necrosectomy With Cryotechnology for Accelerated Removal

Christopher C. Thompson, MD, MSc

NCT06553651

COMPLETED Phase 2 216 participants

A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS

CalciMedica

NCT04681066

COMPLETED Early Phase 1 28 participants

Pentoxifylline Treatment of Acute Pancreatitis

Mayo Clinic

NCT01292005

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2

Named interventions

Most-linked intervention names on Acute Pancreatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

CM-4620 Injectable Emulsion or CM-4620-IE Drug
1 trials
RABI-767 Drug
1 trials
Dexcom Continuous Glucose Monitor (CGM) Device
1 trials
CM4620 Drug
1 trials
biospecimen collection Other
1 trials
survey administration Other
1 trials
Cryotechnology Necrosectomy Procedure Device
1 trials
Endoscopic management of pancreatic fluid collections Procedure
1 trials

US sites by state

Facility locations filed on Acute Pancreatitis trials. A trial with sites in several states counts in each.

Minnesota 6 trials
Florida 6 trials
Illinois 5 trials
California 5 trials
Maryland 4 trials
Washington 3 trials
Pennsylvania 3 trials
Ohio 3 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Acute Pancreatitis page

11 registered trials, 9 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Acute Pancreatitis condition card totals 11 registered trials; most-linked intervention CM-4620 Injectable Emulsion or CM-4620-IE; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.